Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment

European Journal of Neurology

Volumn 17, Issue 1, 2010, Pages

  Nociti, V ^a   Frisullo, G ^a   Tartaglione, T ^a   Patanella, A K ^a   Iorio, R ^a   Tonali, P A ^a   Batocchi, A P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anti GAD antibodies; Cerebellar ataxia; Immunosuppressive treatment; Refractory seizures

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYANOCOBALAMIN; ETIRACETAM; GLUTAMATE DECARBOXYLASE ANTIBODY; OXCARBAZEPINE; PARIETAL CELL ANTIBODY; PHENOBARBITAL; PREDNISONE; PREGABALIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; ANTIBODY TITER; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMORBIDITY; CYANOCOBALAMIN DEFICIENCY; DRUG DOSE REDUCTION; EPILEPSY; FEMALE; GRAND MAL SEIZURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AZATHIOPRINE; BIOLOGICAL MARKERS; BRAIN; CEREBELLAR ATAXIA; DIABETES MELLITUS, TYPE 1; EPILEPSY, GENERALIZED; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HASHIMOTO DISEASE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; NYSTAGMUS, PATHOLOGIC; PREDNISONE; TREATMENT OUTCOME; VITAMIN B 12 DEFICIENCY;

EID: 73449103911     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02839.x     Document Type: Letter

References (7)

1. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990 322 : 1555 1560.
2. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001 58 : 225 230.
3. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005 65 : 1730 1736.
4. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry 2007 78 : 187 189.
5. Tilikete C, Vighetto A, Trouillas P, Honnorat J. Anti-GAD antibodies and periodic alternating nystagmus. Arch Neurol 2005 62 : 1300 1303.
6. Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 1998 352 : 457.
7. Kanter IC, Huttner HB, Staykov D, et al. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 2008 49 : 914 920.